Delivery Order SPE2DB22D3011-SPE2DB24FQ4BG
Award Date
9/20/24
Potential Completion Date
9/23/24
Potential Value
$102K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp. for the supply of pharmaceutical products, specifically IPOL VIAL 5ML. The contract has a ceiling value of $1,067.35 and a total performance period through August 13, 2024. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, has been awarded numerous federal contracts by defense and civilian agencies...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IPOL VIAL 5ML, a pharmaceutical product, and has a firm fixed price ceiling value of $6,584.22. The contract is not set-aside and has a performance period extending through June 12, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $12,645.16, is for the delivery of IPOL VIAL 5ML pharmaceutical products. It is a firm fixed-price contract with a period of performance through May 1, 2025. The contract is not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IPOL VIAL 5ML, a pharmaceutical product, with a ceiling value of $2,134.70 and a completion date of September 16, 2024. The contract is a Firm Fixed Price delivery order, which is not set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,180.20, is for the delivery of IPOL VIAL 5ML, a pharmaceutical product. The contract has a firm fixed price and is scheduled for completion by May 8, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,682.98, is for the delivery of IPOL VIAL 5ML medical supplies. The contract is a firm fixed-price delivery order, with a performance period ending on May 1, 2025. It is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to provide 4,565,577,156 units of IPOL VIAL 5ML. The contract has a firm-fixed-price of $139,262.52 and a period of performance through August 27, 2024. The contract is not set aside for a specific business category. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,270.30, is for the delivery of IPOL VIAL 5ML pharmaceutical products. It is a firm fixed price, non-set-aside contract with a performance period ending on May 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,787.54, is for the delivery of IPOL VIAL 5ML pharmaceutical products. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 6, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corporation is a...
This is a firm fixed-price delivery order award to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of 4565244124 IPOL VIAL 5ML, with a ceiling value of $2,461.60 and a period of performance through July 25, 2024. Amerisourcebergen is a for-profit organization that holds several indefinite delivery contracts (IDCs) with the DLA and Department of Justice,...